SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid): a novel leukotriene antagonist.
Ahnfelt-Rønne
I
I
Department of Pharmacology, Leo Pharmaceutical Products, Ballerup, Denmark.
Kirstein
D
D
Kaergaard-Nielsen
C
C
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001980:Bronchi / Q000187:drug effects; D006168:Guinea Pigs; D007082:Ileum / Q000032:analysis; D020024:Leukotriene Antagonists; D008168:Lung / Q000032:analysis; D011804:Quinolines / Q000494:pharmacology*; D011971:Receptors, Immunologic / Q000032:analysis; D018077:Receptors, Leukotriene; D013189:SRS-A; D014132:Trachea / Q000032:analysis
D001095:Arachidonic Acids; D020024:Leukotriene Antagonists; D011804:Quinolines; D011971:Receptors, Immunologic; D018077:Receptors, Leukotriene; D013189:SRS-A; C059177:SR 2640